HomeBIOBV • HEL
add
Biohit Oyj
Previous close
€2.81
Day range
€2.80 - €2.85
Year range
€2.10 - €4.35
Market cap
34.80M EUR
Avg Volume
9.34K
P/E ratio
-
Dividend yield
-
Primary exchange
HEL
Market news
Financials
Income Statement
Revenue
Net income
| (EUR) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 3.70M | 0.00% |
Operating expense | 1.85M | 12.12% |
Net income | 450.00K | -25.00% |
Net profit margin | 12.16 | -25.03% |
Earnings per share | — | — |
EBITDA | 700.00K | -6.67% |
Effective tax rate | 18.18% | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 5.20M | 4.00% |
Total assets | 17.70M | 24.65% |
Total liabilities | 4.60M | 35.29% |
Total equity | 13.10M | — |
Shares outstanding | 15.18M | — |
Price to book | 3.27 | — |
Return on assets | 8.47% | — |
Return on capital | 10.34% | — |
Cash Flow
Net change in cash
| (EUR) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 450.00K | -25.00% |
Cash from operations | -650.00K | 13.33% |
Cash from investing | 800.00K | — |
Cash from financing | -50.00K | 0.00% |
Net change in cash | 100.00K | 113.33% |
Free cash flow | 343.75K | -12.70% |
About
Biohit Oyj is a Finnish company which develops, manufactures, and markets biotech and diagnostics products for use in research and health care. Wikipedia
Founded
1988
Website
Employees
49
